Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001609722-14-000001
Filing Date
2014-06-03
Accepted
2014-06-03 12:57:21
Documents
1
Period of Report
2014-05-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2033
  Complete submission text file 0001609722-14-000001.txt   3582
Mailing Address 1603 ORRINGTON AVENUE, SUITE 600 EVANSTON IL 60201
Business Address 1603 ORRINGTON AVENUE, SUITE 600 EVANSTON IL 60201 (847) 563-2349
PANTHER BIOTECHNOLOGY, INC. (Issuer) CIK: 0001530981 (see all company filings)

EIN.: 331221758 | State of Incorp.: NV | Fiscal Year End: 0531
SIC: 7389 Services-Business Services, NEC

Mailing Address 474 N LAKE SHORE DR APT 5906 CHICAGO IL 60611
Business Address
Mehta Jayesh (Reporting) CIK: 0001609722 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55074 | Film No.: 14886633